What is the current Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS market capitalization?
The current market capitalization of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS is 2.43 B TRY.
In 2024, Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS's market cap stood at 2.43 B TRY, a -37.72% increase from the 3.9 B TRY market cap in the previous year.
YEAR | Market Capitalization (undefined TRY) |
---|---|
2022 | 2.43 |
2021 | - |
2020 | - |
Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
A yearly comparison of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Variations in Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
The current market capitalization of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS is 2.43 B TRY.
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS.
The market capitalization of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS has increased/decreased by -37.72% compared to the previous year.
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
Over the past 12 months, Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS is expected to pay a dividend of 0 TRY.
The current dividend yield of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS is .
Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS pays a quarterly dividend. This is distributed in the months of .
Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS paid dividends every year for the past 0 years.
For the upcoming 12 months, dividends amounting to 0 TRY are expected. This corresponds to a dividend yield of 0 %.
Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS is assigned to the 'Health' sector.
To receive the latest dividend of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS from 11/10/2023 amounting to 0.415 TRY, you needed to have the stock in your portfolio before the ex-date on 11/8/2023.
The last dividend was paid out on 11/10/2023.
In the year 2023, Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS distributed 0 TRY as dividends.
The dividends of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS are distributed in TRY.
Our stock analysis for Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.